pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioPharma Dive·May 13·1 min read
save

[Podcast] Closing the Distance in Cancer Care

This podcast episode explores the critical role community oncology plays in the U.S. healthcare system and why supporting its growth and autonomy matters for patients and providers.

May 13, 2026·read at BioPharma Dive ↗

An article from Sponsored [Podcast] Closing the Distance in Cancer Care Published May 13, 2026 Share Copy link Email LinkedIn X/Twitter Facebook Print Sponsored content By McKesson SPONSORED CONTENT BY Many people associate advanced cancer treatment with large hospital systems and academic medical centers. But oncology has evolved to expand access to advanced treatment options, clinical trial opportunities, and patient-centered care, all close to home. This podcast episode explores the critical role community oncology plays in the U.S.

healthcare system and why supporting its growth and autonomy matters for patients and providers. Check out the podcast episode below! ⬆ Ep.

1 Community Oncology, a Local Lifeline Today, patients can access high-quality cancer care even if they live far from major academic hospital systems. In this episode, we talk to a practicing oncologist and a healthcare leader who shed light on how community oncology delivers innovative care without requiring extensive travel. Share Copy link Email LinkedIn X/Twitter Facebook Print Filed Under: Pharma, Clinical Trials

source

Reporting by BioPharma Dive.

read at BioPharma Dive ↗
163 words · retrieved May 14
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Oncology9

related stories

  • Apr 27Erasca reports RAS cancer drug data after legal threat from RevolutionEndpoints
  • Apr 27Revolution Medicines threatens to sue Erasca over patent, efficacy claimsEndpoints
  • Apr 27Lilly to buy startup Ajax in bid for a better JAK drugBioPharma Dive
  • Apr 27STAT+: Astellas retries XLMTM gene therapy after deathsSTAT
  • Apr 27Lilly announces a new cancer deal, paying Ajax up to $2.3B for JAK inhibitorEndpoints